Schonfeld Strategic Advisors LLC Galera Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $28,000 - $38,304	11,200 Added 8.23%	147,300 $459,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.68 $201,428 - $364,748	136,100 New	136,100 $348,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.39 $32,984 - $63,574	-26,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.01 - $4.19 $53,465 - $111,454	26,600 New	26,600 $63,000
Q2 2021 Aug 16, 2021	SELL	$6.08 - $10.44 $331,287 - $568,854	-54,488 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $454,974 - $675,106	54,488 New	54,488 $481,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.